<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37-marinedrugs-17-00374" class="ref">
 <label class="label">37.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Mason</surname>
    <given-names class="given-names">R.P.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Jacob</surname>
    <given-names class="given-names">R.F.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Shrivastava</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sherratt</surname>
    <given-names class="given-names">S.C.R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Chattopadhyay</surname>
    <given-names class="given-names">A.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes</article-title>
  <source class="source">Biochim. Biophys. Acta</source>
  <year class="year">2016</year>
  <volume class="volume">1858</volume>
  <fpage class="fpage">3131</fpage>
  <lpage class="lpage">3140</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.bbamem.2016.10.002</pub-id>
  <?supplied-pmid 27718370?>
  <pub-id pub-id-type="pmid" class="pub-id">27718370</pub-id>
 </element-citation>
</ref>
